Search research articles
Contact Us
Filters
Showing results (351-360 of 483) with videos related to
Page
of 49
Sort By:
Scientific Reports
|
March 29, 2026
Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples
Franz Josef Gassner, Gabriel Rinnerthaler, Vanessa Castagnaviz, et al.
Cancers
|
February 25, 2023
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
Laura Urwanisch, Michael Stefan Unger, Helene Sieberer, et al.
Wiener Klinische Wochenschrift
|
March 3, 2012
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)]
Ingrid Pabinger, Günther Gastl, Michael Steurer, et al.
Annals of Hematology
|
June 22, 2014
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma
Heinz Ludwig, Luisa Viterbo, Richard Greil, et al.
The Journal of Pathology
|
March 31, 2015
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation
Olaf Merkel, Frank Hamacher, Robert Griessl, et al.
Blood Advances
|
February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study
Jason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Journal for Immunotherapy of Cancer
|
October 22, 2021
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
Victoria M Leb-Reichl, Melanie Kienzl, Anna Kaufmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2022
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, et al.
Page
of 49
Search research articles
Search
Showing results (351-360 of 483) with videos related to
Sort By:
Page
of 49
Scientific Reports
|
March 29, 2026
Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples
Franz Josef Gassner, Gabriel Rinnerthaler, Vanessa Castagnaviz, et al.
Cancers
|
February 25, 2023
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
Laura Urwanisch, Michael Stefan Unger, Helene Sieberer, et al.
Wiener Klinische Wochenschrift
|
March 3, 2012
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)]
Ingrid Pabinger, Günther Gastl, Michael Steurer, et al.
Annals of Hematology
|
June 22, 2014
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma
Heinz Ludwig, Luisa Viterbo, Richard Greil, et al.
The Journal of Pathology
|
March 31, 2015
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation
Olaf Merkel, Frank Hamacher, Robert Griessl, et al.
Blood Advances
|
February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study
Jason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Journal for Immunotherapy of Cancer
|
October 22, 2021
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
Victoria M Leb-Reichl, Melanie Kienzl, Anna Kaufmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2022
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, et al.
Page
of 49